Ermine phenotype

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:999OMIM:227010E70.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

The Ermine phenotype is a rare form of oculocutaneous albinism (OCA) characterized by a distinctive pigmentation pattern. The name derives from the ermine (stoat in winter coat), as affected individuals are born with white hair and very light skin typical of albinism, but develop small, darkly pigmented spots or patches on the skin over time, resembling the pattern of ermine fur. This condition falls under the broader category of albinism and is classified under ICD-10 code E70.3 (albinism). The pigmentary system is primarily affected, involving the skin, hair, and eyes. Ocular features commonly associated with albinism, such as reduced visual acuity, nystagmus, iris transillumination, and foveal hypoplasia, may be present to varying degrees. The Ermine phenotype has been described in association with mutations in genes involved in melanin biosynthesis, and it is thought to represent a variant presentation within the spectrum of oculocutaneous albinism. The scattered pigmented macules that develop on otherwise hypopigmented skin are a hallmark distinguishing feature. These spots may increase in number and size with age and sun exposure. The condition is congenital, with the characteristic white hair and pale skin evident at birth, while the pigmented spots typically appear during infancy or early childhood. There is no cure for the Ermine phenotype. Management focuses on protecting the skin from ultraviolet radiation through sun-protective clothing, broad-spectrum sunscreen, and sun avoidance to reduce the risk of skin damage and skin cancer. Ophthalmologic care is important, including regular eye examinations, corrective lenses, and low-vision aids as needed. Genetic counseling is recommended for affected families to discuss recurrence risks and inheritance patterns.

Also known as:

Clinical phenotype terms— hover any for plain English:

Ocular albinismHP:0001107
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ermine phenotype.

View clinical trials →

No actively recruiting trials found for Ermine phenotype at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ermine phenotype community →

No specialists are currently listed for Ermine phenotype.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ermine phenotype.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ermine phenotypeForum →

No community posts yet. Be the first to share your experience with Ermine phenotype.

Start the conversation →

Latest news about Ermine phenotype

No recent news articles for Ermine phenotype.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ermine phenotype

What is Ermine phenotype?

The Ermine phenotype is a rare form of oculocutaneous albinism (OCA) characterized by a distinctive pigmentation pattern. The name derives from the ermine (stoat in winter coat), as affected individuals are born with white hair and very light skin typical of albinism, but develop small, darkly pigmented spots or patches on the skin over time, resembling the pattern of ermine fur. This condition falls under the broader category of albinism and is classified under ICD-10 code E70.3 (albinism). The pigmentary system is primarily affected, involving the skin, hair, and eyes. Ocular features common

How is Ermine phenotype inherited?

Ermine phenotype follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ermine phenotype typically begin?

Typical onset of Ermine phenotype is neonatal. Age of onset can vary across affected individuals.